New Age Alpha Advisors LLC Cuts Stock Holdings in HCA Healthcare, Inc. $HCA

New Age Alpha Advisors LLC lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 90.8% during the fourth quarter, Holdings Channel reports. The fund owned 748 shares of the company’s stock after selling 7,351 shares during the period. New Age Alpha Advisors LLC’s holdings in HCA Healthcare were worth $349,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Genus Capital Management Inc. lifted its position in shares of HCA Healthcare by 60.4% during the 4th quarter. Genus Capital Management Inc. now owns 17,896 shares of the company’s stock worth $8,355,000 after purchasing an additional 6,741 shares during the last quarter. Hantz Financial Services Inc. lifted its position in shares of HCA Healthcare by 13.4% during the 4th quarter. Hantz Financial Services Inc. now owns 423 shares of the company’s stock worth $197,000 after purchasing an additional 50 shares during the last quarter. Prospera Financial Services Inc raised its stake in HCA Healthcare by 8.1% during the 4th quarter. Prospera Financial Services Inc now owns 14,429 shares of the company’s stock worth $6,737,000 after acquiring an additional 1,084 shares in the last quarter. Coldstream Capital Management Inc. boosted its stake in HCA Healthcare by 3.3% in the fourth quarter. Coldstream Capital Management Inc. now owns 4,278 shares of the company’s stock valued at $1,997,000 after acquiring an additional 136 shares in the last quarter. Finally, Life Cycle Investment Partners Ltd acquired a new position in HCA Healthcare in the fourth quarter valued at $374,037,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 2.1%

Shares of HCA Healthcare stock opened at $384.01 on Friday. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The company’s 50-day simple moving average is $454.43 and its 200-day simple moving average is $481.46. The firm has a market cap of $85.19 billion, a price-to-earnings ratio of 13.21, a price-to-earnings-growth ratio of 1.24 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same quarter last year, the firm earned $6.45 earnings per share. The company’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Analyst Upgrades and Downgrades

HCA has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research note on Tuesday, April 28th. Truist Financial decreased their price objective on shares of HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a research note on Monday, April 27th. Sanford C. Bernstein decreased their price objective on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a research note on Tuesday, April 28th. Leerink Partners dropped their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Finally, Argus dropped their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $515.77.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.